We Are One Seven »

Biomarin Pharmaceutical shares owned by We Are One Seven

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by We Are One Seven from 13F filings

Historical chart of We Are One Seven investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by We Are One Seven consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by We Are One Seven

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.7k 10k 0.97

More positions owned by We Are One Seven

NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Broadcom Put Option (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core Univrsl Usd (IUSB)
Applied Materials (AMAT)
Bny Mellon Etf Trust Internationl Eqt (BKIE)

View all positions for We Are One Seven

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Oaktree Capital Management
Capstone Investment Advisors
Man Group
Camden Asset Management
Opti Capital Management
MacKay Shields
Jpmorgan Chase & Co
Verition Fund Management
Victory Capital Management
Thrivent Financial for Lutherans
Toronto-Dominion Bank
BlackRock
State Street Corporation
DeepCurrents Investment Group

View all funds holding Biomarin Pharmaceutical